These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 11525101)

  • 21. Choice of fecal occult blood tests for colorectal cancer screening: recommendations based on performance characteristics in population studies: a WHO (World Health Organization) and OMED (World Organization for Digestive Endoscopy) report.
    Young GP; St John DJ; Winawer SJ; Rozen P;
    Am J Gastroenterol; 2002 Oct; 97(10):2499-507. PubMed ID: 12385430
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunochemical testing of individuals positive for guaiac faecal occult blood test in a screening programme for colorectal cancer: an observational study.
    Fraser CG; Matthew CM; Mowat NA; Wilson JA; Carey FA; Steele RJ
    Lancet Oncol; 2006 Feb; 7(2):127-31. PubMed ID: 16455476
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics.
    Allison JE; Sakoda LC; Levin TR; Tucker JP; Tekawa IS; Cuff T; Pauly MP; Shlager L; Palitz AM; Zhao WK; Schwartz JS; Ransohoff DF; Selby JV
    J Natl Cancer Inst; 2007 Oct; 99(19):1462-70. PubMed ID: 17895475
    [TBL] [Abstract][Full Text] [Related]  

  • 24. What can we conclude from the randomized controlled trials of fecal occult blood test screening?
    Lang CA; Ransohoff DF
    Eur J Gastroenterol Hepatol; 1998 Mar; 10(3):199-204. PubMed ID: 9585021
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Screening and rescreening for colorectal cancer. A controlled trial of fecal occult blood testing in 27,700 subjects.
    Kewenter J; Björk S; Haglind E; Smith L; Svanvik J; Ahrén C
    Cancer; 1988 Aug; 62(3):645-51. PubMed ID: 3292038
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence of colorectal diseases in immunological fecal occult blood test (I-FOBT) positive patients in a tertiary care hospital in Bangladesh.
    Mollick SH; Roy PK; Bhuiyan MR; Mia AR; Alam MS; Mollick KA; Pervin S; Hassan MQ
    Mymensingh Med J; 2014 Oct; 23(4):764-9. PubMed ID: 25481598
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Eliminating the need for dietary restrictions when using a sensitive guaiac fecal occult blood test.
    Rozen P; Knaani J; Samuel Z
    Dig Dis Sci; 1999 Apr; 44(4):756-60. PubMed ID: 10219834
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Chemical or immunological tests for the detection of fecal occult blood in colorectal cancer screening?].
    Quintero E
    Gastroenterol Hepatol; 2009 Oct; 32(8):565-76. PubMed ID: 19577340
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of continued mailed fecal tests in the patient-centered medical home: Year 3 of the Systems of Support to Increase Colon Cancer Screening and Follow-Up randomized trial.
    Green BB; Anderson ML; Chubak J; Fuller S; Meenan RT; Vernon SW
    Cancer; 2016 Jan; 122(2):312-21. PubMed ID: 26488332
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mailings timed to patients' appointments: a controlled trial of fecal occult blood test cards.
    Goldberg D; Schiff GD; McNutt R; Furumoto-Dawson A; Hammerman M; Hoffman A
    Am J Prev Med; 2004 Jun; 26(5):431-5. PubMed ID: 15165660
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of changing stool collection processes on compliance in nationwide organized screening using a fecal occult blood test (FOBT) in Korea: study protocol for a randomized controlled trial.
    Shin HY; Suh M; Baik HW; Choi KS; Park B; Jun JK; Lee CW; Oh JH; Lee YK; Han DS; Lee DH
    Trials; 2014 Nov; 15():461. PubMed ID: 25428164
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Randomized controlled trial of the impact of intensive patient education on compliance with fecal occult blood testing.
    Stokamer CL; Tenner CT; Chaudhuri J; Vazquez E; Bini EJ
    J Gen Intern Med; 2005 Mar; 20(3):278-82. PubMed ID: 15836533
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The impact of mailing fecal occult blood test kits on return rate in a community cancer screening center.
    Mahon SM
    Oncol Nurs Forum; 1995 Sep; 22(8):1259-63. PubMed ID: 8532551
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fecal occult blood tests in occult gastrointestinal bleeding.
    Bond JH
    Semin Gastrointest Dis; 1999 Apr; 10(2):48-52. PubMed ID: 10361895
    [TBL] [Abstract][Full Text] [Related]  

  • 35. False positive and negative hemoccult reactions on a normal diet and effect of diet restriction.
    Bassett ML; Goulston KJ
    Aust N Z J Med; 1980 Feb; 10(1):1-4. PubMed ID: 6966493
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Screening tests for occult blood.
    Trotman IF
    Lancet; 1980 May; 1(8176):1036. PubMed ID: 6103374
    [No Abstract]   [Full Text] [Related]  

  • 37. Lower risk of advanced neoplasia among patients with a previous negative result from a fecal test for colorectal cancer.
    Denters MJ; Deutekom M; Bossuyt PM; Stroobants AK; Fockens P; Dekker E
    Gastroenterology; 2012 Mar; 142(3):497-504. PubMed ID: 22108194
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison between a guaiac and three immunochemical faecal occult blood tests in screening for colorectal cancer.
    Faivre J; Dancourt V; Denis B; Dorval E; Piette C; Perrin P; Bidan JM; Jard C; Jung S; Levillain R; Viguier J; Bretagne JF
    Eur J Cancer; 2012 Nov; 48(16):2969-76. PubMed ID: 22572481
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Optimal dietary conditions for hemoccult testing.
    Macrae FA; St John DJ; Caligiore P; Taylor LS; Legge JW
    Gastroenterology; 1982 May; 82(5 Pt 1):899-903. PubMed ID: 7060911
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.